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M A J O R A R T I C L E
Tracking a Tuberculosis Outbreak Over 21 Years:
Strain-Speciﬁc Single-Nucleotide Polymorphism
Typing Combined With Targeted Whole-
Genome Sequencing
David Stucki,1,2,a Marie Ballif,3,a Thomas Bodmer,4,9 Mireia Coscolla,1,2 Anne-Marie Maurer,5 Sara Droz,4 Christa Butz,6
Sonia Borrell,1,2 Christel Längle,4 Julia Feldmann,1,2 Hansjakob Furrer,7 Carlo Mordasini,6 Peter Helbling,8
Hans L. Rieder,10,11 Matthias Egger,3,12 Sébastien Gagneux,1,2 and Lukas Fenner1,2,3,b
1Swiss Tropical and Public Health Institute, 2University of Basel, 3Institute of Social and Preventive Medicine, 4Institute for Infectious Diseases, University
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Bern, 8Federal Ofﬁce of Public Health, Bern, 9labormedizinisches zentrum Dr Risch, Liebefeld-Bern, and 10Institute of Social and Preventive Medicine,
University of Zurich, Switzerland; 11Tuberculosis Department, International Union Against Tuberculosis and Lung Disease, Paris, France; and 12School of
Public Health and Family Medicine, University of Cape Town, South Africa
Background. Whole-genome sequencing (WGS) is increasingly used in molecular-epidemiological investigations
of bacterial pathogens, despite cost- and time-intensive analyses. We combined strain-speciﬁc single-nucleotide poly-
morphism (SNP) typing and targetedWGS to investigate a tuberculosis cluster spanning 21 years in Bern, Switzerland.
Methods. On the basis of genome sequences of 3 historical outbreak Mycobacterium tuberculosis isolates, we
developed a strain-speciﬁc SNP-typing assay to identify further cases. We screened 1642 patient isolates and per-
formed WGS on all identiﬁed cluster isolates. We extracted SNPs to construct genomic networks. Clinical and social
data were retrospectively collected.
Results. We identiﬁed 68 patients associated with the outbreak strain. Most received a tuberculosis diagnosis in
1991–1995, but cases were observed until 2011. Two thirds were homeless and/or substance abusers. Targeted WGS
revealed 133 variable SNP positions among outbreak isolates. Genomic network analyses suggested a single origin of
the outbreak, with subsequent division into 3 subclusters. Isolates from patients with conﬁrmed epidemiological
links differed by 0–11 SNPs.
Conclusions. Strain-speciﬁc SNP genotyping allowed rapid and inexpensive identiﬁcation of M. tuberculosis out-
break isolates in a population-based strain collection. Subsequent targeted WGS provided detailed insights into transmis-
sion dynamics. This combined approach could be applied to track bacterial pathogens in real time and at high resolution.
Keywords. tuberculosis; outbreak; whole genome sequencing; genomic epidemiology; screening.
Tuberculosis transmission has traditionally been in-
vestigated using contact tracing and molecular typing
[1, 2]. However, social contact data are often hard to
obtain retrospectively, especially in high-risk groups
such as homeless individuals and substance abusers,
who are difﬁcult to trace [3–7]. Moreover, classical
molecular epidemiological techniques such as IS6110
restriction fragment-length polymorphism (RFLP)
analysis and mycobacterial interspersed repetitive unit
– variable number of tandem repeat (MIRU-VNTR)
analysis interrogate only a small proportion of the
mycobacterial genome and therefore suffer from limited
resolution [8].
More recently, whole-genome sequencing (WGS) of
Mycobacterium tuberculosis has been used to investi-
gate tuberculosis outbreaks [9]. Known as “genomic
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epidemiology” [10], this emerging ﬁeld uses WGS to detect un-
known transmission events, identify superspreaders, and ex-
clude or conﬁrm epidemiologically suspected transmission
links [11–14]. Moreover, WGS can also be used to detect drug
resistance mutations [15]. Even though routine WGS has the
potential to replace classical genotyping [14, 16], analyzing
WGS data remains resource-intensive and requires further
standardization to meet public health needs, particularly for
tracking ongoing outbreaks in real time [9].
In 1993, a tuberculosis outbreak was reported in the canton
of Bern, Switzerland [17]. Twenty-two cases were involved, and
their M. tuberculosis isolates shared identical IS6110 RFLP pat-
terns. As in other afﬂuent countries [18, 19], this outbreak in-
volved mainly homeless individuals and substance abusers. In
2012, we studied the molecular epidemiology of tuberculosis
in Switzerland. We used the classic methods of spoligotyping
and MIRU-VNTR to genotype 520 M. tuberculosis isolates
from patients in whom tuberculosis was diagnosed between
2000 and 2008 (12.3% of all culture-conﬁrmed tuberculosis
cases in Switzerland during the study period) [20]. Among 68
isolates from the canton of Bern, 2 were identiﬁed as belonging
to the same outbreak described in 1993, indicating that this par-
ticular strain was still circulating in the area.
In the present study, we used a combination of single-
nucleotide polymorphism (SNP) typing and targeted WGS to
track the spread of the outbreak over 2 decades. Using represen-
tative isolates from the historical outbreak, we ﬁrst developed a
novel strain-speciﬁc SNP-typing assay to rapidly and inexpen-
sively identify all tuberculosis cases caused by this strain in the
canton of Bern between 1991 and 2011. We then applied target-
edWGS to all cluster isolates identiﬁed by the screening assay to
study the outbreak dynamics in relation to social contact
information.
METHODS
Study Setting and Sample Set
We subcultured 1642 patient isolates available from the M. tu-
berculosis strain collection at the Institute for Infectious Diseas-
es (Bern, Switzerland). These isolates were all collected between
1991 and 2011 and correspond to 84.6% of all 1940 tuberculosis
cases (all forms) notiﬁed in the canton of Bern during the same
period (Figure 1). Subcultures were performed on Löwenstein-
Jensen slants according to international laboratory standards.
Puriﬁed DNA for WGS was obtained using the CTAB extrac-
tion method after subculturing a single colony in 7H9 liquid
medium [21]. Bulk extracts (ie, without single colony selection)
were available for 4 isolates.
The collection included the 22 historical outbreak isolates re-
ported by Genewein et al [17].One strain isolated in 1987, before
systematic collection was started in 1991, was also included
(P028, originally termed “patient 1” [17]). Finally, for 1 outbreak
patient from 1991, we identiﬁed an additional strain isolated in
1988 (P006A, originally termed “patient 2”; Figure 1).
Cluster Strain–Speciﬁc SNP-Typing Assay and Screening of
Strain Collection
We performed WGS on 1 historical outbreak isolate from 1992
[17] and 2 isolates from 2005 and 2008 with the same MIRU-
VNTR and spoligotyping patterns [20] associated with the so-
called Bernese cluster, as described below. We also performed
WGS on 2 isolates with the same spoligotyping pattern (isola-
tion years, 2001 and 2004) but a different MIRU-VNTR pattern
(3 and 4 different loci, compared with the outbreak isolate),
1 additional lineage 4 isolate from another study, and the refer-
ence strain H37Rv (Figure 2). The 3 outbreak isolates shared
Figure 1. Overview of patient isolates and whole genome sequences
generated. A total of 1642 isolates collected between 1991 and 2011
were available for single-nucleotide polymorphism (SNP) genotyping.
Three isolates showed ambiguous SNP-typing results and were excluded.
One additional patient isolate (P028; isolated in 1987) reported in the orig-
inal publication [17] and predating the systematic collection of isolates in
1991 was included in the study. For the key patient, a second isolate
(P006B; isolated in 1991 [17]) was available and was included in the ge-
nomic analyses.
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118 SNPs not observed in any of the control isolates (Figure 2).
We used one of these outbreak-speciﬁc SNPs (878 174 GA; posi-
tion in reference to H37Rv) to develop a real-time polymerase
chain reaction (PCR) SNP-typing assay (TaqMan, Life Technol-
ogies, Switzerland), as described previously [22]. All 1642 avail-
able isolates were screened for the presence of that SNP. For
conﬁrmation, we subjected all isolates with a mutation at this po-
sition to a second, phylogenetically redundant SNP-typing assay
(981 565 CT). Both SNPs were selected to be synonymous and
located in genomic regions suitable for primer and probe design.
WGS and Phylogenetic Analyses
All isolates identiﬁed by the screening assay and the additional
serial isolate from patient P006 were subjected to Illumina WGS
at GATC Biotech (Konstanz, Germany), with a median nucleo-
tide coverage of 157.3 reads (range, 29.1–896.9 reads). Sequence
read mapping and SNP calling was done as previously described
[23]. We considered SNPs with a coverage of at least 10 sequenc-
ing reads and a value of 20 in the Phred-scaled quality score.
SNPs in genes annotated as “PE/PPE/PGRS,” “maturase,”
“phage,” “insertion sequence,” or “13E12 repeat family protein”
were removed. Additionally, positions with missing nucleotide
calls in at least 3 isolates were excluded. We used a second
short-read alignment tool (SMALT, Wellcome Trust Sanger In-
stitute, United Kingdom) to obtain SNP calls. Only positions
called by both methods after ﬁltering for the criteria mentioned
above were included for further analysis. A subset of 28 SNPs was
conﬁrmed by Sanger sequencing (Supplementary Materials).
A genomic network with all variable positions was generated
using Fluxus Network Software (http://www.ﬂuxus-engineering.
com) and the median joining algorithm. Arlequin 3.5.1.12 [24]
was used to calculate genetic distances and ﬁxation indices (FST)
to estimate population separation between genomic subclusters.
Statistical signiﬁcance was calculated with permutations.
Raw sequencing data are available under accession number
PRJEB5925 (European Nucleotide Archive).
Clinical and Sociodemographic Data Collection
We collected clinical and sociodemographic data for all patients
identiﬁed as belonging to the cluster. Treating physicians, hos-
pital archives, the Bernese Lung Association, and the cantonal
health authorities collected the data, using standardized ques-
tionnaires. We also collected contact tracing information for
conﬁrmed or presumptive links among cluster patients. The
Figure 2. Initial neighbor joining phylogeny of Mycobacterium tubercu-
losis isolates. Three whole-genome sequences from the historic outbreak
and 4 control isolates were used to identify single-nucleotide polymor-
phisms (SNPs) speciﬁc to the outbreak genotype. Node support was as-
sessed by bootstrapping over 1000 pseudo-replicates and is indicated as
a percentage.
Figure 3. Epidemic curve of the 68 patients identiﬁed as tuberculosis cluster cases. Gray boxes indicate patients associated with the social milieu
(homeless individuals and/or substance abusers). One additional patient isolate (P028; isolated in 1987) reported in the original publication [17] and pre-
dating the systematic collection of isolates in 1991 was included in the study. For 1 patient from 1991 [17], a second isolate (P006A; isolated in 1988) was
available and was therefore backdated.
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National Tuberculosis Surveillance Registry (Federal Ofﬁce of
Public Health) provided basic demographic data (age, sex,
birth place, and disease site) for all tuberculosis cases notiﬁed
in the canton of Bern between 1991 and 2011.
Deﬁnitions
We categorized patients as having new tuberculosis, recurrent
tuberculosis, or an unknown previous treatment status, accord-
ing to international deﬁnitions [25]. Links between cases were
considered conﬁrmed for contacts named in the contact tracing
information. Links between cases were considered presumptive
when contacts were not clearly named but were strongly
supported by other contact tracing information (ie, visiting
common hotspots of transmission, shared housing, and shared
place of work). Alcohol abuse was deﬁned as daily consumption
of alcohol, and smoking was deﬁned as past or current smoking.
We deﬁned “milieu” as a combined variable capturing high-risk
populations (substance abusers and/or homeless individuals)
and/or patients frequenting high-risk settings (ie, drug injection
places, methadone distribution places, and homeless shelters).
Statistical Analyses
We used χ2 tests or Fisher exact tests to assess differences be-
tween groups in binary variables and the Wilcoxon rank sum
Table 1. Comparison of Tuberculosis Outbreak Tracking Methods, Considering the Scenario of the Present Study (68 Outbreak Patients
of 1642 Patient Isolates to Be Screened)
This Study
WGS of Entire
Collection
(n = 1642)
MIRU-VNTR
(n = 1642)
Spoligotyping
(n = 1642) Contact Tracing
SNP Assay for
Identification of
Cluster Isolates
(n = 1642)
Targeted WGS of
Identified Cluster
Isolates (n = 69)
Estimated cost, US$a
Per isolate 3 (SNP assay) 330 (targeted
WGS)
330 49 26 High
Total 4926b (SNP assay) 22 770 (targeted
WGS)
541 860 80 458 42 692 . . .
Advantages Rapid identification
of cluster
isolates;
inexpensive
Highest
resolution
among cluster
isolates;
additional
information
(eg, drug
resistance
mutations)
Highest resolution
among all
isolates (in all
clusters);
additional
information
obtained (eg,
drug resistance
mutations)
Current gold-
standard for
molecular
epidemiology;
can be
semiautomatized
Low technology
requirement
Information on
transmission
hotspots for
targeted
prevention;
information on
secondary
cases
Disadvantages No further
resolution among
cluster isolates;
performance of
assay depends
on selection of
initial isolates for
WGS (eg, SNP
selection)
Previous
identification
of outbreak
isolates
necessary
Expensive;
extensive
bioinformatic
expertise
necessary
Limited resolution
within outbreak
clusters
Low resolution
of outbreak
cluster
analysis when
used as single
method
Expensive and
time-
consuming;
misses many
cases,
particularly in
high-risk
populations
Prospective
use
Can be used in real
time once
outbreak is
identified and an
assay
established;
highest
resolution among
outbreak isolates
if used in
combination with
targeted WGS
In combination
with SNP
assay
Can be used in real
time once
bioinformatics
expertise is
established
Routine use Yes Yes
Abbreviations: MIRU-VNTR, mycobacterial interspersed repetitive unit–variable number of tandem repeat; SNP, single-nucleotide polymorphism; WGS, whole-
genome sequencing.
a Cost calculations were based on commercially available services (http://www.genoscreen.fr and http://www.gatc-biotech.com) or estimated according to in-house
costs (as of August 2014). The total cost of SNP and targeted WGS analyses in this study was US$27 696.
b For WGS of 6 initial isolates and screening using the strain-specific SNP-genotyping assay of 1642 isolates.
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test for analysis of continuous variables. We investigated differ-
ences between (1) the characteristics of patients in the Bernese
cluster and all other notiﬁed tuberculosis cases in the canton of
Bern between 1991 and 2011 and (2) patients in the genomic
subclusters.
Ethics Statement
Ethics approval for this study was obtained from the ethics
committee of the canton of Bern. The treating physicians
sought written informed consent from study participants. In
most cases, however, informed consent could not be obtained
because the patient could not be located or was known to
have died. We therefore obtained permission from the Federal
Expert Commission on Conﬁdentiality in Medical Research to
use the data provided by the treating physicians.
Role of the Funding Sources
The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the article.
RESULTS
Identiﬁcation of Bernese Cluster Isolates by Strain-Speciﬁc
SNP Typing
Using the strain-speciﬁc real-time PCR SNP-typing assay, we
screened 1642M. tuberculosis single patient isolates for the Ber-
nese cluster–speciﬁc SNP (878 174 GA) and identiﬁed 71 of
1642 (4.3%) isolates as belonging to this cluster. All isolates
but 3 were conﬁrmed by use of a second, phylogenetically re-
dundant SNP (981 565 CT). These 3 isolates with ambiguous
results were excluded from further analysis, as subsequent
WGS revealed mean pair-wise distances of 91, 148, and 174
SNPs to the other cluster isolates. In contrast, all other cluster
isolates were separated by ≤19 SNPs (Supplementary Table 1).
This corresponds to a speciﬁcity of 99.8% (3 false-positive re-
sults out of 1574 noncluster isolates), when considering our
screening results based on only the ﬁrst strain-speciﬁc SNP.
All 22 historical isolates described in 1993 [17] were correctly
identiﬁed by both SNP-typing assays (sensitivity, 100%) as hav-
ing Bernese cluster genotype. Hence, we identiﬁed a total of 68
patients linked to the cluster strain (Figures 1 and 3).
For one patient, 2 isolates (P006A and P006B, isolated in
1988 and 1991, respectively) were available, and we included
both for further analyses because of the central role of this pa-
tient described in the original study (originally termed “patient
2” [17]). Hence, we included 69 cluster isolates in the WGS
analyses (Figure 1).
To illustrate the strengths of our novel combined approach, we
compared the costs, advantages, and disadvantages of the differ-
ent methods used in outbreak investigations of tuberculosis
(Table 1). Our strain-speciﬁc SNP assay to screen 1642 isolates
was approximately 15 times less expensive than the current gold
standard based on MIRU-VNTR. A combination of the SNP
assay and targetedWGS for 69 cluster isolates was approximate-
ly 20 times less expensive than performing WGS of the entire
collection.
Description of the Tuberculosis Cluster Over 21 Years
Of the 68 patients in the Bernese cluster, 55 (80.9%) received their
diagnosis during 1998 or earlier, and 13 received their diagnosis
between 1999 and 2011 (Figure 3). The characteristics of the 68
Table 2. Characteristics of Cases Conﬁrmed to Be in the
Tuberculosis Cluster, Compared With All Other Notiﬁed
Tuberculosis Cases, in the Canton of Bern Between 1991 and 2011
Characteristic
Bernese Cluster
Cases (n = 68)
Other Cases
(n = 1872)
P
Value
Age at tuberculosis
diagnosis, y
41 (34–53) 44 (29–71) .12
Sex <.001
Male 54 (79.4) 1072 (57.3)
Female 14 (20.6) 800 (42.7)
Birth region <.001
Switzerland 57 (83.8) 888 (47.4)
Europe (without
Switzerland)
10 (14.7) 398 (21.3)
Sub-Saharan Africa 0 227 (12.1)
Asia 1 (1.5) 284 (15.2)
Caribbean and Latin
America
0 31 (1.7)
Other 0 36 (1.9)
Unknown 0 8 (0.4)
Tuberculosis site <.001
Pulmonary 64 (94.1) 1406 (75.1)
Extrapulmonary 4 (5.9) 466 (24.9)
Tuberculosis category
New case 54 (79.4) . . .
Recurrent 7 (10.3) . . .
Unknown 7 (10.3) . . .
Imprisonment within
2 y of diagnosis
9 (13.2) . . .
Diabetes 3 (4.4) . . .
Alcohol abuse 39 (57.4) . . .
Smoker 41 (60.3) . . .
Injection drug user 18 (26.5) . . .
Homeless 21 (30.9) . . .
HIV positive 13 (19.1) . . .
Homeless/substance
abuser milieu
46 (67.6) . . .
Residence
Bern City 37 (54.4) . . .
Outside Bern City 29 (42.6) . . .
Unknown 2 (2.9) . . .
Data are no. (%) patients or median (interquartile range). Data for some
characteristics were missing for the other cases notified to the Canton of Bern.
Abbreviation: HIV, human immunodeficiency virus.
1310 • JID 2015:211 (15 April) • Stucki et al
cluster patients, compared with characteristics of all other tubercu-
losis cases diagnosed in the same region and period, are presented
in Table 2. Cluster patients were more likely to be male (79.4% vs
57.3%; P < .001), born in Switzerland (83.8% vs 47.4%; P < .001),
and to have pulmonary tuberculosis as opposed to extrapulmo-
nary tuberculosis (94.1% vs 75.1%; P < .001). The median age of
the cluster patients was 41 years (interquartile range [IQR], 34–
53 years), compared with 44 years (IQR, 29–71 years) for all
other patients with tuberculosis (P = .12). Most (67.6%) of the
cluster patients were part of the local injection drug scene and/
or homeless milieu. Among cluster patients, 19.1% were infected
with human immunodeﬁciency virus (HIV; HIV information was
unavailable for noncluster patients). Four particular hotspots of
tuberculosis transmission were identiﬁed within the milieu: 1
short-term homeless shelter, 1 long-term social integration home,
1 meeting point for injection drug and methadone supply, and 1
bar where substance abusers met. The distribution of cluster pa-
tients among these 4 transmission hotspots, the social milieu,
and the general population are presented in Figure 4.
Contact investigation provided information on potential
patient-to-patient links (Figure 4). Fourteen of 68 patients
(20.6%) had conﬁrmed epidemiological links (Figure 4).
Conﬁrmed links were more frequent between patients sharing
transmission hotspots, indicating the large degree of social in-
teraction in these settings. Only 1 conﬁrmed link, between a fa-
ther and his daughter (P040-P041), was identiﬁed in the general
population.
WGS of Bernese Cluster Isolates
A total of 133 variable positions were identiﬁed among the 69
cluster isolates (Supplementary Table 2). We generated a medi-
an joining network using these 133 variable positions (Figure 5).
Despite identical MIRU-VNTR and spoligotyping patterns
(Supplementary Table 3), 52 of 69 isolates (75.4%) were dis-
criminated by at least 1 SNP from their most closely related
neighbor. The maximum number of SNPs between any 2 iso-
lates was 19 (Supplementary Table 1), and the mean pair-wise
distance (±SD) between all isolates was 6.0 ± 2.9 SNPs. Patient
isolates with conﬁrmed epidemiological links differed by 0–11
SNPs (Supplementary Table 1). No drug resistance–associated
mutation was detected among the 69 cluster isolates (Supple-
mentary Materials).
Subclusters and Key Patient
The genomic network revealed 3 independent star-like struc-
tures, suggesting (1) an early divergence of a shared ancestor
strain into 3 subclusters (Figure 5A) and (2) the presence of
one or several superspreaders. A fourth, more distantly related
subcluster was separated by 9 SNPs from the nearest isolate
(P006A; Figure 5A). In contrast, subclusters 1 and 2 were sep-
arated by 1 SNP, and subclusters 1 and 3 were separated by 2
SNPs. The average pairwise distance within each subcluster
was 4.2 (subcluster 1), 3.1 (subcluster 2), 5 (subcluster 3),
and 9.3 SNPs (subcluster 4). All corresponding SNP distances
were larger between subclusters than within subclusters (4.8
Figure 4. Distribution of cluster patients with tuberculosis in the milieu of substance abusers and homeless people. The 4 main hotspots of transmission
that were identiﬁed by social contact tracing are shown (a short-term homeless shelter, a long-term social integration home, a meeting point for substance
abusers, and a bar). Milieu patients are associated with a particular social context (homeless, substance abuser scene). Solid lines indicate conﬁrmed
epidemiological links, and dashed lines indicate suspected social links. Presumptive individual links between milieu patients are not shown because these
patients are highly interlinked.
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Figure 5. Median Joining network using 133 variable single nucleotide positions (SNP) among whole genome sequences ofMycobacterium tuberculosis
cluster isolates of the “Bernese cluster” outbreak. Branch lengths correspond to number of SNPs. Circle sizes correspond to number of isolates, median
vectors (mv) are hypothetical genotypes. Position of “mv6” is the root of the network. A, Network showing the four identiﬁed “sub-clusters. Darker circles in
each subcluster indicate patients that were associated with the particular social milieu (homeless, substance abuser scene), lighter circles are patients in
the non-milieu population. Underlined labels represent isolates that were identiﬁed in the original publication [17]. B, Network colored according to time
period when the M. tuberculosis strains were isolated. C, Network showing patients associated with a particular hotspot.
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SNPs between subclusters 1 and 2, 6.8 SNPs between subclus-
ters 1 and 3, 12.2 SNPs between subclusters 1 and 4, 7.3 SNPs
between subclusters 2 and 3, 12.6 SNPs between subclusters 2
and 4, and 14.6 SNPs between subclusters 3 and 4). Pairwise
ﬁxation indices (FST) between subclusters were between 0.24
(subcluster 1 and 2) and 0.67 (subcluster 2 and 4; P < .005
for all comparisons), further supporting the subcluster
distinction.
The central position of subcluster 1 was occupied by the ﬁrst
isolate from the key patient, patient P006 (P006A; isolated in
1988) together with isolate P010. The second isolate from the
key patient (P006B; isolated 1991) was found in the central po-
sition of subcluster 2. This suggests a second tuberculosis epi-
sode in patient P006, generating further secondary cases.
Seven other isolates were genomically clustered with P006B
and could also be the source of transmission in subcluster
2. However, patient P006 was a homeless substance abuser
who was known to have interrupted treatment and had a history
of treatment failure, and a key role for this patient in the out-
break was already suspected in 1993.
The central position of subcluster 3 remained unoccupied (ie,
no isolate was available with this hypothetical genotype). This
could be explained by an unsampled strain variant from patient
P002 (ie, from a mixed infection of microevolved strains) that
had been transmitted to other subcluster 3 patients. Such a
variant would have been missed as a result of the single colony
isolation step preceding WGS. Manual inspection of the corre-
sponding Sanger sequence trace ﬁles generated from a separate
DNA preparation without the single colony isolation step re-
vealed a double peak at the SNP separating P002 from the hy-
pothetical node mv2 (genomic position 2 156 041) in the bulk
isolate of P002, indicating the presence of a mixed population in
P002. Alternatively, an unsampled patient isolate (reported as
“A,” “B,” and “C” by Genewein et al [17]) might correspond
to the central position of subcluster 3.
When plotting the period of isolation ofM. tuberculosis strains
in the genomic network (Figure 5B), we found no evidence that
the different subclusters were associated with speciﬁc periods.
Finally, we compared the patient characteristics between
the subclusters, excluding subcluster 4 (genetically distant, epi-
demiologically unrelated) and patient P006, whose isolates be-
longed to both subclusters 1 and 2. We found that HIV
infection was more frequent in subcluster 1 (7 of 17 [41.2%])
than in the other subclusters (3 of 30 [9.7%] in subcluster 2
and 3 of 17 [17.6%] in subcluster 3; P = .04). All 3 subclusters
included a majority of individuals from the social milieu (12 of
17 [70.6%] in subcluster 1, 17 of 30 [56.7%] in subcluster 2, and
14 of 17 [82.4%] in subcluster 3; P = .19). Subcluster 3 was
Figure 5 continued.
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associated with 2 particular transmission hotspots: a long-term
social integration home (1 of 17 [5.9%] in subcluster 1, 0 of 30
in subcluster 2, and 7 of 17 [41.2%] in subcluster 3; P < .001;
Figure 5C), and a meeting point for methadone supply (1 of
17 [5.9%] in subcluster 1, 1 of 30 [3.3%] in subcluster 2, and
5 of 17 [29.4%] in subcluster 3; P = .02).
DISCUSSION
Using a novel combination of a rapid and inexpensive strain-
speciﬁc SNP screening assay and targeted WGS, we tracked a
tuberculosis cluster spanning 21 years and revealed the trans-
mission dynamics among the outbreak patients.
Our study demonstrated the feasibility and advantages of
tracking a tuberculosis outbreak by using a strain-speciﬁc
SNP-based screening assay in a large population-based col-
lection of M. tuberculosis isolates. We subsequently performed
targeted WGS on the 69 identiﬁed cluster isolates, which, com-
bined with social contact data, enabled us to retrace transmis-
sion dynamics at high resolution. The combined cost of 6
initial whole-genome sequences used to design the SNP-typing
assay and the subsequent population-wide screening by real-
time PCRwas low (approximately US$4900), compared with the
cost of screening all isolates with any other genotyping method.
Additionally, the time required for screening was substantially
reduced, making this a powerful approach for identifying and
tracking tuberculosis outbreaks in real time. Even though our
study was retrospective, our approach could be used to screen
isolates prospectively.
Our results indicate that the sensitivity and speciﬁcity of this
approach are nearly 100%. However, we could only estimate the
technical test characteristic because WGS data were not avail-
able for the entire collection. Importantly, the performance of
a strain-speciﬁc SNP-typing assay depends on the selection of
SNPs, and the selection of SNPs depends on the isolates initially
sequenced. For the successful design of such an assay, we rec-
ommend the following: (1) select at least 2 known clustered iso-
lates for WGS, (2) include at least 2 control isolates with
genotyping patterns closely related to but different from those
of the clustered isolates (eg, MIRU-VNTR), (3) identify SNPs
speciﬁc to all clustered isolates and absent in the control iso-
lates, (4) exclude SNPs in genes known to be associated with
drug resistance, (5) select SNPs suitable for probe and primer
design, and (6) use at least 2 SNPs for the screening of isolates,
as the speciﬁcity of each SNP might vary.
Using our combined approach and linking it to clinical and
contact tracing data, we found that the tuberculosis cluster con-
tinued to propagate in Bern, mainly in particular transmission
hotspots and in the originally described high-risk populations
of substance abusers and homeless people [17]. This is consis-
tent with previous reports from other low-incidence settings
[4, 19, 26, 27]. The outbreak involved a key patient who caused
numerous secondary cases, which corresponds to superspreader
behavior. Most outbreak cases occurred between 1991 and 1995,
followed by 16 years of sporadic cases, the majority of which
were likely cases of reactivation tuberculosis. The cases in the
early 1990s coincided with known peaks of heroin abuse in
Switzerland. However, 32.4% of all cluster cases involved the
nonmilieu population, possibly reﬂecting transmission from
the milieu to the wider community. In retrospect, more second-
ary cases could have been identiﬁed if our novel screening
method had been available in the 1990s. Indeed, strain-speciﬁc
SNP typing would have provided an inexpensive method to
identify outbreak cases more rapidly. Furthermore, targeted
WGS would have identiﬁed superspreaders in a context where
contact tracing is particularly difﬁcult. Such superspreader be-
havior could have then been targeted with intensiﬁed control
measures to interrupt transmission.
The targeted WGS analyses of all cluster isolates identiﬁed by
strain-speciﬁc SNP typing shed new light on the transmission
dynamics of the outbreak, compared with traditional genotyp-
ing methods. Whereas MIRU-VNTR and spoligotyping showed
identical genotyping patterns, WGS revealed distinct genotypes
for 76.5% of the Bernese cluster isolates. In particular, we iden-
tiﬁed 4 genomic subclusters not revealed by classical genotyp-
ing, likely reﬂecting concomitant but independent clusters of a
common ancestral strain. However, the genetic distances be-
tween subclusters were small (1, 2, and 3 SNPs between subclus-
ters 1, 2, and 3), and therefore the deﬁnition of “subcluster”may
be debatable. The subclusters were, however, supported by FST
values indicating separation of these populations.
Two sequential isolates from the key patient, isolated in 1988
and 1991, occupied the central positions of subclusters 1 and 3,
respectively. This suggests that 2 disease episodes of this patient
led to 2 independent star-like patterns in the genomic network,
indicating superspreader behavior [12–14]. The central role of
this patient was already suspected in the original description of
the outbreak [17]. Hence, WGS analyses indicated that this pa-
tient likely caused more secondary cases than previously assumed.
Despite the many advantages of WGS, our results also showed
that interpreting WGS data has limitations. For example, nearly
25% of cluster isolates were genomically indistinguishable from at
least 1 other isolate. This emphasizes the need to include repeti-
tive regions of the genome that are currently excluded because of
technical limitations [28, 29]. Furthermore, there is increasing
evidence that bacterial populations within patients are heteroge-
neous as a consequence of ongoing microevolution, further com-
plicating the interpretation of transmission events [30]. In our
study, genomes were generated from single colonies for most iso-
lates. Yet, considering potential clonal variants that were ran-
domly excluded from the sequencing process could inﬂuence
the way transmission events are inferred. With improving se-
quencing technologies, future studies should sequence bulk
isolates rather than single colonies and consider within-host
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heterogeneity in bacterial populations. Mutations can also arise
during laboratory culture; these could be avoided by performing
WGS directly from sputum [31].
In conclusion, our strain-speciﬁc SNP-based screening ap-
proach offers a rapid and inexpensive way of tracking tubercu-
losis outbreaks retrospectively and prospectively. This novel
screening method, combined with targeted WGS, can be
used to guide control interventions by rapid and inexpensive
screening, revealing transmission hotspots and missing links
in transmission chains. Future studies could use this approach
in real time to track ongoing outbreaks of tuberculosis and
other infectious diseases in hospital settings, as well as popu-
lation-wide.
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